What Comes Next?
Once the deal closes—expected in April or May 2025 pending regulatory approvals—CentralReach will continue operating independently. Its leadership team, product offerings, and brand will remain intact, ensuring continuity for its extensive client base.
Roper’s legal team includes King & Spalding partners Rahul Patel and John Anderson, while counsel for the other parties has yet to be disclosed.
This acquisition solidifies Roper’s position in the rapidly expanding healthtech sector and signals a significant step forward in the digitization of autism and IDD care.
